Schäfer K, Schumann R R, Stöteknuel S, Schollmeyer P, Dobos G J
University Hospital Freiburg, Department of Nephrology, Germany.
Nephrol Dial Transplant. 1998 Apr;13(4):969-74. doi: 10.1093/ndt/13.4.969.
Bacterial peritonitis is a frequent complication during treatment of end-stage renal failure by continuous ambulatory peritoneal dialysis. Local host defence mechanisms including the secretion of proinflammatory cytokines by peritoneal macrophages are of particular importance in the pathogenesis of infectious complications. LPS-binding protein (LBP) and soluble CD14 (sCD14) are serum factors known to regulate the endotoxin-induced cellular immune response. However, it is still unknown whether LBP and sCD14 are also present in the peritoneal effluent of CAPD patients.
Using specific immunoassays, we examined the concentration of LBP, sCD14 and the proinflammatory cytokines TNF-alpha, IL-1beta and IL-6 in the dialysis effluents of 31 patients with CAPD-associated peritonitis. Twenty patients without peritonitis served as controls. Intraperitoneal LPS concentrations were determined using the limulus amebocyte lysate assay.
Bacterial lipopolysaccharide could be detected in 42% of the infected dialysis effluents. In comparison to controls (0.2 +/- 0.05 microg/ml), LBP was significantly elevated in both gram-negative/LPS-positive (1.03 +/- 0.3 microg/ml) and gram-positive infections (0.5 +/- 0.14 microg/ml) (P<0.05). No significant differences were detected concerning the intraperitoneal sCD14 levels in the three patient groups. Levels of TNF-alpha, IL-1beta and IL-6 were significantly increased in the effluents of patients with bacterial peritonitis compared to noninfected controls. Moreover the respective cytokine concentrations were significantly higher in the gram-negative/LPS-positive compared to the gram-positive bacterial infections (P<0.01).
Our data demonstrate that LBP is significantly elevated in the dialysis effluents of patients with CAPD-associated peritonitis caused by both gram-negative and gram-positive bacteria and might be used as a marker of intraperitoneal infection. Moreover, our findings support the concept that LBP enhances the effects of LPS on cytokine production by peritoneal macrophages. The function of LBP in gram-positive infection remains to be further elucidated.
细菌性腹膜炎是持续性非卧床腹膜透析治疗终末期肾衰竭过程中常见的并发症。包括腹膜巨噬细胞分泌促炎细胞因子在内的局部宿主防御机制在感染性并发症的发病机制中尤为重要。脂多糖结合蛋白(LBP)和可溶性CD14(sCD14)是已知可调节内毒素诱导的细胞免疫反应的血清因子。然而,CAPD患者的腹膜透析液中是否也存在LBP和sCD14仍不清楚。
我们使用特异性免疫测定法,检测了31例CAPD相关性腹膜炎患者透析液中LBP、sCD14以及促炎细胞因子TNF-α、IL-1β和IL-6的浓度。20例无腹膜炎患者作为对照。使用鲎试剂法测定腹腔内脂多糖浓度。
42%的感染性透析液中可检测到细菌脂多糖。与对照组(0.2±0.05微克/毫升)相比,革兰阴性/LPS阳性感染组(1.03±0.3微克/毫升)和革兰阳性感染组(0.5±0.14微克/毫升)的LBP均显著升高(P<0.05)。三组患者腹腔内sCD14水平未检测到显著差异。与未感染的对照组相比,细菌性腹膜炎患者透析液中TNF-α、IL-1β和IL-6水平显著升高。此外,革兰阴性/LPS阳性细菌感染组的各细胞因子浓度显著高于革兰阳性细菌感染组(P<0.01)。
我们的数据表明,革兰阴性和革兰阳性细菌引起的CAPD相关性腹膜炎患者的透析液中LBP显著升高,可能用作腹腔内感染的标志物。此外,我们的研究结果支持LBP增强脂多糖对腹膜巨噬细胞细胞因子产生作用的观点。LBP在革兰阳性感染中的作用仍有待进一步阐明。